GODREJIND2026-04-012026-06-30GODREJIND2026-06-30GODREJIND2026-04-012026-06-30in-capmkt:OtherExpenses1MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments1MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments2MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments3MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments4MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments5MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments6MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments7MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments8MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments9MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments1MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments2MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments3MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments4MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments5MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments6MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments7MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments8MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments9MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments1MemberGODREJIND2026-06-30in-capmkt:ReportableSegments1MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments2MemberGODREJIND2026-06-30in-capmkt:ReportableSegments2MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments3MemberGODREJIND2026-06-30in-capmkt:ReportableSegments3MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments4MemberGODREJIND2026-06-30in-capmkt:ReportableSegments4MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments5MemberGODREJIND2026-06-30in-capmkt:ReportableSegments5MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments6MemberGODREJIND2026-06-30in-capmkt:ReportableSegments6MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments7MemberGODREJIND2026-06-30in-capmkt:ReportableSegments7MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments8MemberGODREJIND2026-06-30in-capmkt:ReportableSegments8MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments9MemberGODREJIND2026-06-30in-capmkt:ReportableSegments9MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments1MemberGODREJIND2026-06-30in-capmkt:ReportableSegments1MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments2MemberGODREJIND2026-06-30in-capmkt:ReportableSegments2MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments3MemberGODREJIND2026-06-30in-capmkt:ReportableSegments3MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments4MemberGODREJIND2026-06-30in-capmkt:ReportableSegments4MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments5MemberGODREJIND2026-06-30in-capmkt:ReportableSegments5MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments6MemberGODREJIND2026-06-30in-capmkt:ReportableSegments6MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments7MemberGODREJIND2026-06-30in-capmkt:ReportableSegments7MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments8MemberGODREJIND2026-06-30in-capmkt:ReportableSegments8MemberGODREJIND2026-04-012026-06-30in-capmkt:ReportableSegments9MemberGODREJIND2026-06-30in-capmkt:ReportableSegments9MemberGODREJIND2026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1GODREJIND2026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1GODREJIND2026-04-012026-06-30AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares500164GODREJINDNOTLISTEDINE233A01035Godrej Industries LimitedMain BoardEquity2026-04-012027-03-312026-08-132026-08-06INRCroresQuarterlyFirst quarterMulti segment2026-08-1312:30:002026-08-1313:10:00Declaration of unmodified opinion2026-04-012026-06-30UnauditedConsolidated544809000009122100000636030000002911370000031392400000-275847000005542900000745140000013337000001026980000057519200000608380000006083800000962500000112590000020884000000399540000000012382000005233600000-500000005183600000284360000023900000002780300000240330000033680000018.448.44008.448.440.02380.01650.04021. The above Statement of unaudited financial results which are published in accordance with Regulation 33 and 52 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on August 13, 2026. The financial results are in accordance with the Indian Accounting Standards (Ind-AS) as prescribed under section 133 of the Companies Act, 2013 read with the relevant rules thereunder. The above results have been reviewed by the Statutory Auditors of the Company who have expressed an unmodified review conclusion vide their review reports thereon. <br /> <br /> 2. During the quarter ended June 30, 2026, under the Employee Stock Grant Scheme, the Company has granted 35,998 stock grants to eligible employees of the Company. Upon vesting, as per the Scheme, equivalent number of equity shares of nominal value of Re. 1 each in the Company shall be issued to the eligible employees on exercising their grants. <br /> <br /> 3. On November 21, 2025 the Government of India notified four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 , and the Occupational Safety, Health and Working Conditions Code, 2020 - consolidating 29 existing labour laws. The Company/Group had assessed and disclosed the incremental impact of these changes basis actuarial valuation and management estimates and had accounted an additional gratuity and leave benefits liability of Rs. 65.81 crore in the Consolidated Financial results for the year ended March 31, 2026, as an Exceptional item. <br /> <br /> 4. Pursuant to the share purchase agreement with the Promoter Group of Creamline Dairy Products Limited, Godrej Agrovet Limited a subsidiary company, had acquired the balance equity stake of 36.79% during the quarter ended June 30, 2025 for Rs. 708.58 crore in Creamline Dairy Products Limited. During the quarter ended September 30, 2025, Godrej Agrovet Limited further acquired 0.46% equity stake for Rs. 8.93 crore thereby increasing the equity stake to 99.78% in Creamline Dairy Products Limited. As at June 30, 2026 Godrej Agrovet Limited is in the process of acquiring the balance 0.22% equity stake. Accordingly, Profit attributable to Non-controlling interest are not comparable to that extent. <br /> <br /> 5. The Board of Directors of Astec LifeSciences Limited (Subsidiary Company of Godrej Agrovet Limited) at its meeting held on June 30, 2025, has inter-alia, approved the Letter of Offer and Rights Issue of 28,01,673 (Twenty Eight Lakh One Thousand Six Hundred and Seventy-Three) fully paid-up Equity Shares of face value of Rs. 10 (Ten) each, for an aggregate amount not exceeding Rs. 249.35 Crore (Rupees Two Hundred and Forty-Nine Crore and Thirty Five Lakh Only) at the issue price of Rs. 890/- (Rupees Eight Hundred and Ninety Only) per share in the Rights Entitlement ratio of 1 (One) fully paid-up rights equity share for every 7 (Seven) fully paid up equity share, of face value Rs. 10 (Ten) each, held by the eligible equity shareholders of Astec LifeSciences Limited as on Record date, July 04, 2025. The Issue opened on Monday, July 14, 2025 and closed on Monday, July 28, 2025. Other terms of the Issue were included in the Letter of Offer for the Issue. Accordingly, Godrej Agrovet Limited a subsidiary company had participated in the said Rights issue and equity shares have been allotted on July 29, 2025. Consequent to the rights issue, the shareholding % in Astec LifeSciences Limited has increased to 67.03% as at June 30, 2026. Accordingly, Profit attributable to Non-controlling interest are not comparable to that extent. <br /> <br /> 6. The Hon'ble National Company Law Tribunal ('NCL T') dated 8 July 2026 has pronounced the order to merge Embellish Houses Private Limited (a wholly owned subsidiary of Godrej Properties Limited, a subsidiary company) with Godrej Properties Limited with effect from 1 November 2025 (the appointed date) along with directions to Godrej Properties Limited to file the certified copy of the Order, the scheme of amalgamation and some other compliance documents with the concerned Registrar of Companies ('RoC') post which the merger will be considered as effective. Godrej Properties Limited is in the process of completing the necessary formalities, within the timelines stipulated as per the order, post which the order will be considered as effective. Pending the process of making Scheme effective, the Group has not given effect to the NCLT order during the quarter ended 30 June 2026. <br /> <br /> 7. The Board of Directors of Godrej Capital Limited (Subsidiary Company of Godrej Investment Limited, a subsidiary company) , at its meeting held on July 03, 2026, approved a scheme of amalgamation of Godrej Finance Limited (Transferor Company) with Godrej Capital Limited (Transferee Company) in accordance with Section 233 and other applicable provisions of the Companies Act, 2013. The Transferor Company is wholly-owned subsidiary of the Transferee Company and, accordingly shares will be issued pursuant to the amalgamation. Further, the listed non-convertible debentures of the Transferor Company will be transferred to the Transferee Company without any change in their existing terms and conditions. Godrej Finance Limited has filed an application to the Reserve Bank of India in relation to the proposed scheme and approval is yet to be received. <br /> <br /> 8. Pursuant to SEBI Circular no. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021 read with Circular no. SEBI/HO/DDHS/DDHS_Div1/P/CIR/2022/0000000103 dated July 29, 2022, the Company and its subsidiary(ies) have listed Commercial Papers and listed Unsecured Non convertible debentures on concerned Stock Exchange(s). <br /> <br /> 9. Formulae used for Calculation of Key Ratios and Financial indicators: <br /> Debt Equity Ratio (Gross) = Total Debt /Equity <br /> Debt Equity Ratio (Net) = DEBT [Borrowings (excluding Lease Liabilities accounted as per Ind AS 116) - Cash and Bank Balance (includes FD) - Liquid Investments] / Equity <br /> Debt Service Coverage Ratio = EBITDA / [Interest Expense + Repayment of Long Term Borrowings during the period (netted off to the extent of Long term Loans availed during the same period for the repayments)] <br /> Interest Service Coverage Ratio = EBITDA / Interest Expense <br /> EBITDA = Net Profit/(Loss) Before Tax + Interest Expense + Depreciation and Amortisation Expenses+Loss/(Profit) (net) on sale of Property, Plant and Equipment <br /> Current Ratio = Current Assets/Current Liabilities <br /> Long term Debt to Working Capital = Non Current Borrowing / (Current assets-Current Liabilities) <br /> Bad Debts to Accounts Receivable Ratio = Bad Debts/Accounts Receivable <br /> Current Liability Ratio = Current Liabilities /Total Liabilities <br /> Total Debt to Total Assets = (Non Current Borrowing+Current Borrowing)/Total Assets <br /> Debtors Turnover = Revenue from Operations / Average Trade Receivable <br /> Inventory Turnover = (Cost of Materials Consumed + Purchases of Stock in Trade + Changes in Inventories of Finished Goods, Stock in Trade and Work in Progress) / Average Inventory <br /> Operating profit ratio = (Earnings before exceptional item, interest, taxes, depreciation, amortization expenses less Other Income/ Revenue from operations) <br /> Net Profit Margin = Profit/(Loss) for the period/ Revenue from Operations <br /> Net Worth= As defined in sub-section (57) of section 2 of the Companies Act,2013. <br /> <br /> For Table refer PDF filing done at Stock exchanges. <br /> <br /> 10. In view of acquisitions and changes in the Company’s / Group's shareholdings during the period in some of the subsidiaries, joint ventures and associates, the consolidated results for the current period are not strictly comparable with those of the previous periods. <br /> <br /> 11. The Company is in compliance with the requirements of the Chapter XII of SEBI Master circular dated October 15, 2025 applicable to Large Corporate Borrowers. <br /> <br /> 12. The figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures in respect of the full financial year and the published year to date figures upto the third quarter of that financial year.Other Expenses10269800000Chemicals11606300000Animal Nutrition13020900000Veg Oils7696600000Estate and Property Development13348600000Finance and Investments9656300000Dairy4646300000Crop Care3490200000Hospitality299200000Others135010000065114500000151150000063603000000Chemicals1592200000Animal Nutrition846900000Veg Oils889600000Estate and Property Development5018200000Finance and Investments1004100000Dairy-19000000Crop Care755500000Hospitality68800000Others7130000010227600000281750000013263000006083800000Chemicals29765400000Animal Nutrition22030700000Veg Oils11314800000Estate and Property Development881507400000Finance and Investments358160400000Dairy7825100000Crop Care20526800000Hospitality7985600000Others6385600000134550180000068448000001352346600000Chemicals9374900000Animal Nutrition14407000000Veg Oils1788700000Estate and Property Development678772200000Finance and Investments258046700000Dairy3609200000Crop Care10396800000Hospitality7664000000Others219620000098625570000012908240000011153381000001. Unallocable expenditure includes general and administrative expenses and other expenses incurred on common services at the corporate level and relate to the Group as a whole. <br /> <br /> 2. Others includes seeds business, poultry, cattle breeding, energy generation through windmills. <br /> <br /> 3. Segment Revenue Reconciliation in terms of the measure reported to the Chief Operating Decision Maker: <br /> <br /> For Table refer PDF filing done at Stock exchanges. <br /> <br /> Amount of items that will not be reclassified to profit and loss2140000021400000-2000000Amount of items that will be reclassified to profit and loss-51200000-5120000022200000-50000000UnauditedtrueKalyaniwalla & Mistry LLPtrue2027-07-31